Hereditary degenerative retinopathies: Optimism for somatic gene therapy

被引:4
|
作者
Shastry, BS [1 ]
机构
[1] Oakland Univ, Eye Res Inst, Rochester, MI 48309 USA
关键词
animal models; degeneration; gene; mutation; retinitis pigmentosa;
D O I
10.1080/15216540050167007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Retinitis pigmentosa comprises a large and exceptionally heterogeneous group of hereditary disorders of the retina, iis a result of an extensive investigation around the world, primary genetic lesions have been described in many genes, Some of these genes encode enzymes that are involved in the signal transduction pathway. On the basis of in vitro functional assays and standard transgenic and knock-out experiments, it has been proposed that normal cell functions are disrupted because of an abnormal protein-folding and metabolic errors or structural defects in the membrane. This ultimately leads to a gene-mediated cell death known as apoptosis, Various gene transfer approaches using mouse models further suggest that the degeneration can be rescued to some extent. Although many questions remain to be answered, investigations during the last 10 years have enormously increased our understanding of this exceptionally heterogeneous disorder and give hope for an effective gene therapy and a possible cure.
引用
收藏
页码:479 / 484
页数:6
相关论文
共 50 条
  • [31] Improved adenoviral vectors: Cautious optimism for gene therapy
    Channon, KM
    George, SE
    QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS, 1997, 90 (02): : 105 - 109
  • [32] Gene therapy for the treatment of degenerative disk disease
    Hubert, Mark G.
    Vadala, Gianluca
    Sowa, Gwendolyn
    Studer, Rebecca K.
    Kang, James D.
    JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS, 2008, 16 (06) : 312 - 319
  • [33] Pathogenesis of degenerative retinopathies induced by thioridazine and other antipsychotics: A dopamine hypothesis
    Fornaro P.
    Calabria G.
    Corallo G.
    Picotti G.B.
    Documenta Ophthalmologica, 2002, 105 (1) : 41 - 49
  • [34] Both cardiac function and life expectancy of hereditary dilated cardiomyopathy (HDCM) were improved by somatic gene therapy
    Toyo-oka, T
    Kawada, T
    Nakazawa, M
    Nakatsuru, Y
    Sakamoto, A
    Yamazaki, K
    Shimamoto, R
    Shin, WS
    Suzuki, JI
    Ozawa, K
    EUROPEAN HEART JOURNAL, 2001, 22 : 625 - 625
  • [35] GENE THERAPY FOR HEREDITARY METABOLIC LEUKOENCEPHALOPATHIES
    Aubourg, Patrick
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 885 - 885
  • [36] Is somatic cell gene therapy ethical?
    Gerstenbrand, F.
    Huber, S.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 285 : S17 - S17
  • [37] Topical aspects of somatic gene therapy
    Licht, T
    Hafkemeyer, P
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1999, 124 (22) : 700 - 706
  • [38] Gene therapy in hereditary retinal dystrophy
    Chien, Jia-Ying
    Huang, Shun-Ping
    TZU CHI MEDICAL JOURNAL, 2022, 34 (04): : 367 - 372
  • [39] Gene therapy for hereditary hearing loss
    Fu, Zeming
    Zhao, Liping
    Guo, Yingyuan
    Yang, Jingpu
    HEARING RESEARCH, 2025, 455
  • [40] Gene therapy for hereditary bullous epidermolysis
    Meneguzzi, G
    Ortonne, JP
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2000, 127 (03): : 329 - 332